Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms

Author：                

Publisher： Spandidos Publications

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.6, Iss.1, 2012-01, pp. : 88-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-angiogenic therapy for osteosarcoma

By Quan Gerald  

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 707-713

Springer Publishing Company

Access to resources Recommend Favorite

Indole-3-ethylsulfamoylphenylacrylamides with Potent Anti-proliferative and Anti-angiogenic Activities

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 7, 2016-05 ,pp. : 907-913

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Tumor Microenvironment in Mediating Response to Anti-angiogenic Therapy

By Jung Y.D.  

Cancer and Metastasis Reviews, Vol. 19, Iss. 1-2, 2000-06 ,pp. : 147-157

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer

By                

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 439-445

Spandidos Publications

Access to resources Recommend Favorite

Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma

By Lu Kan V   Bergers Gabriele  

CNS Oncology, Vol. 2, Iss. 1, 2013-01 ,pp. : 49-65

Future Medicine

Access to resources Recommend Favorite